Wellstar/TMI Imaging System Being Utilized in Breast Cancer Study at Duke University Medical Center
21 Noviembre 2008 - 8:50AM
Marketwired
Wellstar International, Inc. (OTCBB: WLSI), a provider of
specialized diagnostic software and equipment, announced today that
the Department of Radiation Oncology at Duke University Medical
Center (DUMC) has disclosed its utilization of the Trillenium
Medical Imaging system ("TMI") to validate the system's potential
to measure the clinical response rates to novel therapies indicated
in recurrent breast cancer patients.
According to Oana Craciunescu, the medical physicist for this
study at DUMC, "The TMI Medical Imaging System has been implemented
since the spring of 2007; the study's principal objective is to
examine the system's ability to help clinicians decide if patients
are responding to treatment. Preliminary observations of the
effectiveness of the Wellstar/TMI system are encouraging, although
more data needs to still be collected. The number of patients
monitored to date under this study has been minimal."
At the annual meeting of the Society for Thermal Medicine
earlier this year in Munich, Germany, Dr. Blackwell, the Principal
Investigator of the study, and Dr. Oana Craciunescu presented
information on this unique study. The DUMC group intends to publish
complete results on this imaging study following the completion of
the Phase I trial in early 2009.
ABOUT WELLSTAR INTERNATIONAL, INC.:
Wellstar International, Inc., through its wholly owned operating
subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to
become a leading diagnostic company in the health care industry.
TMI has developed and is marketing fully calibrated and functional,
thermal imaging systems that utilize state-of-the-art infrared
technologies and proprietary software to accurately and
cost-effectively measure physiological changes in the human body.
More information on the Company and its unique diagnostic software
and product line is available on Wellstar's corporate Website by
visiting: www.wellstar.us.
FORWARD-LOOKING STATEMENTS:
This press release contains statements, which may constitute
'forward-looking statements' within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Prospective
investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those contemplated by such forward-looking statements. Important
factors currently known to management that could cause actual
results to differ materially from those in forward-statements
include fluctuation of operating results, the ability to compete
successfully and the ability to complete before-mentioned
transactions. The company undertakes no obligation to update or
revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future
operating results.
CONTACT: Equiti-trend Advisors LLC (800) 953-3350 Toll-Free,
U.S. & Canada (858) 436-3350 Local or International 9:30 a.m.
to 5:00 p.m. Daily
Wellstar (CE) (USOTC:WLSI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Wellstar (CE) (USOTC:WLSI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024